Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge

被引：0
作者：
Rescigno, Pasquale [1 ,2 ]
Rodrigues, Daniel Nava [1 ,2 ]
de Bono, Johann S. [1 ,2 ]
机构：
[1] Inst Canc Res, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
来源：
BJU INTERNATIONAL | 2017年 / 119卷 / 01期
关键词：
ABIRATERONE;
D O I：
10.1111/bju.13550
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [21] TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
    Lee, Geun Taek
    Rosenfeld, Jeffrey A.
    Kim, Won Tae
    Kwon, Young Suk
    Palapattu, Ganesh
    Mehra, Rohit
    Kim, Wun-Jae
    Kim, Isaac Yi
    [J]. PLOS ONE, 2019, 14 (09):
  • [22] In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
    Theil, Gerit
    Boehm, Catrin
    Fischer, Kersten
    Bialek, Joanna
    Hoda, Raschid
    Weber, Ekkehard
    Schonburg, Sandra
    Kawan, Felix
    Fornara, Paolo
    [J]. ONCOLOGY LETTERS, 2021, 21 (05)
  • [23] Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
    Ritch, Elie
    Wyatt, Alexander W.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 380 - 384
  • [24] Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate Cancer
    Neal, David
    Lilja, Hans
    [J]. EUROPEAN UROLOGY, 2016, 70 (06) : 993 - 994
  • [25] A Systematic Review of Circulating Tumor Cells Clinical Application in Prostate Cancer Diagnosis
    Enikeev, Dmitry
    Morozov, Andrey
    Babaevskaya, Diana
    Bazarkin, Andrey
    Malavaud, Bernard
    [J]. CANCERS, 2022, 14 (15)
  • [26] Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
    Lorente, David
    Olmos, David
    Mateo, Joaquin
    Bianchini, Diletta
    Seed, George
    Fleisher, Martin
    Danila, Daniel C.
    Flohr, Penny
    Crespo, Mateus
    Figueiredo, Ines
    Miranda, Susana
    Baeten, Kurt
    Molina, Arturo
    Kheoh, Thian
    McCormack, Robert
    Terstappen, Leon W. M. M.
    Scher, Howard I.
    de Bono, Johann S.
    [J]. EUROPEAN UROLOGY, 2016, 70 (06) : 985 - 992
  • [27] BIOMARKERS FOR CHARACTERIZATION AND THERAPEUTIC ORIENTATION IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Plata Bello, Ana
    Tamayo Jover, Marco Antonio
    Gutierrez Nicolas, Fernando
    Acosta Lopez, Silvia
    Concepcion Masip, Tomas
    Plata Bello, Julio
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (02): : 195 - 202
  • [28] Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment
    Yang, Mei
    Zhang, Xiaotian
    Guo, Lixia
    Liu, Xiumin
    Wu, Jing
    Zhu, Hongquan
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [29] Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
    Miyamoto, David T.
    Lee, Richard J.
    Stott, Shannon L.
    Ting, David T.
    Wittner, Ben S.
    Ulman, Matthew
    Smas, Malgorzata E.
    Lord, Jenna B.
    Brannigan, Brian W.
    Trautwein, Julie
    Bander, Neil H.
    Wu, Chin-Lee
    Sequist, Lecia V.
    Smith, Matthew R.
    Ramaswamy, Sridhar
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    [J]. CANCER DISCOVERY, 2012, 2 (11) : 995 - 1003
  • [30] Circulating cell-free DNA: Translating prostate cancer genomics into clinical care
    Tandefelt, Delila Gasi
    de Bono, Johann
    [J]. MOLECULAR ASPECTS OF MEDICINE, 2020, 72
12345